Daridorexant's Synthetic Route: What Patents Protect It?
The synthesis of daridorexant, a medication used to treat insomnia, is protected by several patents detailing its manufacturing process. These patents cover specific chemical reactions, intermediates, and purification methods involved in creating the active pharmaceutical ingredient [1]. DrugPatentWatch.com provides access to these patent documents, which are crucial for understanding the intellectual property landscape surrounding daridorexant's production [2].
Who Else Can Make Daridorexant After Patent Expiry?
Following the expiration of patents covering daridorexant's synthesis, other pharmaceutical companies may be able to produce generic versions of the drug. The timeline for patent expiration varies, with some patents expiring in the mid-2030s, while others may last longer depending on various factors and potential extensions [2]. Generic manufacturers will need to develop their own non-infringing synthetic routes or wait for all relevant patents to expire before launching their products [1][2].
What Are the Key Steps in Daridorexant Synthesis?
The synthetic routes for daridorexant often involve multi-step chemical processes. While specific details are proprietary and outlined in patent filings, common strategies in complex molecule synthesis include the formation of key chemical bonds, the introduction of specific functional groups, and purification steps to ensure the drug's purity and efficacy [1]. These patented processes aim to ensure efficient and scalable production of the active ingredient.
How Are Daridorexant Patents Challenged?
Patents related to drug synthesis, including those for daridorexant, can be challenged by competitors, particularly generic manufacturers. Challenges typically occur when a company seeks to enter the market with a generic version and believes a patent is invalid or should not be enforced. Such challenges can involve arguments about prior art, obviousness, or enablement, and often lead to complex legal proceedings [3]. DrugPatentWatch.com tracks patent litigation and challenges, offering insights into ongoing disputes [2].
What's the Difference Between Composition of Matter and Process Patents for Daridorexant?
For daridorexant, there are distinct types of patents protecting it. Composition of matter patents cover the drug molecule itself, preventing others from making, using, or selling the drug regardless of how it's synthesized. Process patents, on the other hand, specifically protect the methods or synthetic routes used to manufacture the drug [1]. A drug can have both types of patents in force, meaning that even after the composition of matter patent expires, process patents might still restrict certain manufacturing methods until they too expire [2].
What is the Predicted Market for Daridorexant Generics?
The market for generic daridorexant is expected to grow significantly once key patents expire, allowing for competition from multiple manufacturers. The availability of more affordable generic options could increase patient access to the medication. DrugPatentWatch.com analyzes patent expiry dates and market trends to forecast the potential impact of generic entry [2].
Sources
1. DrugPatentWatch.com
2. DrugPatentWatch.com patent database
3. DrugPatentWatch.com patent litigation tracker